Technical Data
V2121-30N
VEGFC, Recombinant, Rat (Vascular Endothelial Growth Factor C, VEGF-C, Flt4 Ligand, Flt4-L, Vascular Endothelial Growth Factor-related Protein, VRP)
10ug
|
Technical Data |
|
V2121-30N |
VEGFC, Recombinant, Rat (Vascular Endothelial Growth Factor C, VEGF-C, Flt4 Ligand, Flt4-L, Vascular Endothelial Growth Factor-related Protein, VRP) |
10ug |
| Growth Factors, Cytokines | Storage: -20°CShipping: Blue Ice |
|
VEGF-C (Vascular Endothelial Growth Factor-C) is a 129aa recombinant protein that lacks the N-terminal and C-terminal extensions and contains only the middle third VEGF homology domain. Source: Recombinant corresponding to rat VEGFC expressed in E. coli. Molecular Weight: ~15kD Endotoxin Level: <0.1ng/ug Biological Activity: Activity of VEGF-C will be tested by the stimulation of VEGF-R3 phosphorylation in cells transfected with VEGF-R3. The expected ED50 is 200ng/ml. Storage and Stability: Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with acetic acid. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. Molecular Weight: ~15kD |
Source: E. coli Purity: ~90% (SDS-PAGE) Concentration: ~0.1-1mg/ml after reconstitution Form: Supplied as a lyophillized powder. Reconstitute in 0.1% acetic acid to 0.1-1mg/ml. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|
|
||